Advanced Pain Institute of Texas Announces New Clinical Trials Start - Cross Timbers Gazette |  Southern Denton County |  Flower hill

When Dr. John Broadnax and Dr. Eric Anderson opened the Advanced Pain Institute of Texas in 2017, their goal was to set the standard in interventional pain management.

To do this, they not only had to exceed expectations in terms of the quality of care, they also had to commit to promoting the field. It also means that you are the first medical research opportunity that could one day give patients access to therapies to which they would otherwise not have access.

To say these visions are becoming a reality would be an understatement. The Advanced Pain Institute of Texas, your source for world-class, minimally invasive, multidisciplinary pain management, is now leading multiple clinical research studies to evaluate new innovative therapies for chronic pain sufferers.

One of them in particular is a novel spinal cord stimulator therapy that, when combined with existing treatments, could create a long overdue breakthrough in long-term pain relief.

“To say that we are happy to be a part of it,” said Dr. Anderson, “would be an understatement. Where conventional treatments could fail for some patients, we could offer these patients additional options. “

Dr. Broadnax agreed, adding that this study could have a tremendous impact on the advancement of the pain management field.

“This is an important study in the interventional pain world,” he said. “It could open up exciting new treatment options for patients in the future.”

Pain management practices abound throughout the Dallas-Fort Worth area, all from head to toe touting for the treatment of back and neck pain to an excruciating case of plantar fasciitis. The Advanced Pain Institute of Texas is the only North Texas practice invited to participate in this study.

Dr. Broadnax said the study is ongoing. Candidates include patients with low back pain who have not had lumbar spine surgery and are not candidates for lumbar spine surgery.

“Once the study is complete, it will give us better guidance on how to best apply the therapy to the patients who will best benefit from it,” said Dr. Anderson.

To learn more, visit

(Sponsored Content)